Research for profit

BMJ 2006; 332 doi: 10.1136/bmj.332.7550.1155-c (Published 11 May 2006)
Cite this as: BMJ 2006;332:1155.4

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Des Spence (destwo@yahoo.co.uk), general practitioner
  1. Glasgow G20 9DR

    EDITOR—The stumbling block for clinical trials in both the developing and developed world is the same, enrolment.1 It is difficult to enrol patients into trials, and we rely on consent forms and the investigating doctor to protect patients.

    Unknown to most patients, however, is the conflict of interest that exists at the time of enrolment. When I …

    Access to the full text of this article requires a subscription or payment

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    THIS WEEK'S POLL